These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prevention and therapy of respiratory distress syndrome in premature infants by means of bromhexine metabolite VIII. Animal experimental studies on the therapeutic efficacy of bromhexine metabolite VIII in premature respiratory distress syndrome]. Endell W, Grosspietzsch R, Klink F, von Klitzing L, Oberheuser F. Fortschr Med; 1977 Sep 22; 95(25):2145-8. PubMed ID: 242957 [Abstract] [Full Text] [Related]
4. Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results . Kuckelt W, Dauberschmidt R, Scharfenberg J, Winsel K, Lachmann B, Frenzke H, Hieronymi U, Mrochen H, Meyer M. Respiration; 1980 Sep 22; 39(5):264-71. PubMed ID: 7414106 [Abstract] [Full Text] [Related]
5. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)]. Wiessmann KJ, Niemeyer K. Arzneimittelforschung; 1978 Sep 22; 28(5a):918-21. PubMed ID: 373777 [Abstract] [Full Text] [Related]
6. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology]. Hoffmann H. Arzneimittelforschung; 1978 Sep 22; 28(5a):931-3. PubMed ID: 581993 [No Abstract] [Full Text] [Related]
7. [Effect of Lasolvan on the course of respiratory distress syndrome in newborn infants]. Bajorek J, Czeszyńska M, Gizejowska M, Baryła-Pankiewicz E. Pediatr Pol; 1987 Jun 22; 62(6):382-7. PubMed ID: 3670928 [No Abstract] [Full Text] [Related]
15. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation]. Minuto A, Corino T, Ceccopieri M, Bardi F. Clin Ter; 1984 Dec 31; 111(6):521-30. PubMed ID: 6396029 [No Abstract] [Full Text] [Related]
16. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases. Primbs K. Clin Ther; 1985 Dec 31; 7(6):733-6. PubMed ID: 4075364 [Abstract] [Full Text] [Related]
17. [Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis]. Zapletal A, Vávrová V, Stefanová J, Horák J, Samánek M. Cesk Pediatr; 1983 Sep 31; 38(9):519-24. PubMed ID: 6640752 [No Abstract] [Full Text] [Related]
18. Effect of bromhexine, ambroxol, and placebo on clinical and histopathological changes in "Sjögren" mice. Prause JU, Jensen OA, Manthorpe R. Graefes Arch Clin Exp Ophthalmol; 1985 Sep 31; 223(5):259-64. PubMed ID: 4065592 [Abstract] [Full Text] [Related]
19. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo. Marini A, Franzetti M, Gios G, Flauto U, Arosio A, Maccabruni M, Rondini G, Chirico G, Giancola A, Console V. Respiration; 1987 Sep 31; 51 Suppl 1():60-7. PubMed ID: 3299568 [Abstract] [Full Text] [Related]
20. [Tissue-plasminogen-activators of maternal and fetal rat lungs after application of betamethasone or bromhexine-metabolite VIII (author's transl)]. Haas-Denk S, Krieglsteiner P, Wriedt-Lübbe I, Erhardt W, Münnich W, Blümel G. Z Geburtshilfe Perinatol; 1976 Dec 31; 180(6):398-403. PubMed ID: 1014776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]